Skip to main content

Animations

MJFF Publications

5851 - 5860 of 6431 Results
Title
Year
  • Year
  • 2019
  • 2024
  • 2019
  • 2019
  • 2014
  • 2014
  • 2019
  • 2019
  • 2025
  • 2022
  • Summary Details
    OPEN
    Title: Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30141-3
    Citation Count: 112
  • Summary Details
    OPEN
    Title: Genetic and clinical study of PARK7 in Japanese Parkinson's disease
    Journal Name: Heliyon
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.heliyon.2024.e35271
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Screening of the glucocerebrosidase (GBA) gene in South Africans of African ancestry with Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2019.12.011
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30140-1
    Citation Count: 88
  • Summary Details
    OPEN
    Title: Temporal Characteristics of High-Frequency Lower-Limb Oscillation during Freezing of Gait in Parkinson’s Disease
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2014/606427
    Citation Count: 25
  • Summary Details
    OPEN
    Title: Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2014.05.012
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Free-water imaging of the hippocampus is a sensitive marker of Alzheimer's disease
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2019.101985
    Citation Count: 52
  • Summary Details
    OPEN
    Title: Effectiveness of home-based and remotely supervised aerobic exercise in Parkinson's disease: a double-blind, randomised controlled trial
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30285-6
    Citation Count: 460
  • Summary Details
    OPEN
    Title: Distinct brain atrophy progression subtypes underlie phenoconversion in isolated REM sleep behaviour disorder
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105753
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Regulation of Αlpha-Synuclein Gene (SNCA) by Epigenetic Modifier TET1 in Parkinson Disease
    Journal Name: International Neurourology Journal
    Publisher: Korean Continence Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.5213/inj.2222206.103
    Citation Count: 10
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.